New Nordic Healthbrands AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0001838038
SEK
16.35
-0.3 (-1.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
BioGaia AB
New Nordic Healthbrands AB
Midsona AB
AAK AB
Wntresearch AB
Veg of Lund AB
DanCann Pharma A/S
Eevia Health Plc
Nicoccino Holding AB
Hemply Balance Holding AB

Why is New Nordic Healthbrands AB ?

1
  • NET PROFIT(HY) Higher at SEK 3.5 MM
  • ROCE(HY) Highest at 8.08%
  • DEBTORS TURNOVER RATIO(HY) Highest at 6.08 times
2
With ROE of 4.85%, it has a fair valuation with a 1.35 Price to Book Value
  • Over the past year, while the stock has generated a return of 17.63%, its profits have risen by 151.1% ; the PEG ratio of the company is 0.2
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to New Nordic Healthbrands AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is New Nordic Healthbrands AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
New Nordic Healthbrands AB
17.63%
-0.13
55.56%
OMX Stockholm 30
10.97%
0.59
18.59%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.19%
EBIT Growth (5y)
-14.06%
EBIT to Interest (avg)
6.62
Debt to EBITDA (avg)
1.79
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
3.80
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.82%
ROE (avg)
5.79%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
1.35
EV to EBIT
16.67
EV to EBITDA
13.01
EV to Capital Employed
1.27
EV to Sales
0.29
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
7.63%
ROE (Latest)
4.85%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Bearish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
NET PROFIT(HY)

Higher at SEK 3.5 MM

ROCE(HY)

Highest at 8.08%

DEBTORS TURNOVER RATIO(HY)

Highest at 6.08 times

RAW MATERIAL COST(Y)

Fallen by -222.78% (YoY

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS

Here's what is working for New Nordic Healthbrands AB

Net Profit
At SEK 3.5 MM has Grown at 156.16%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (SEK MM)

Net Profit
Higher at SEK 3.5 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

Debtors Turnover Ratio
Highest at 6.08 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -222.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales